Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.
about
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseasesPathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromesThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisEltrombopag in aplastic anemiaNumerical analysis of in vivo platelet consumption data from ITP patientsSuspects in the tale of lupus-associated thrombocytopenia.New insights into the mechanisms of nonimmune thrombocytopenia in neonates.Pathobiology of secondary immune thrombocytopenia.Treatment of immune thrombocytopenic purpura: focus on eltrombopag.Thrombopoietin and platelet production in chronic immune thrombocytopenia.New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different EtiologiesThrombopoietin: a potential diagnostic indicator of immune thrombocytopenia in pregnancy.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.Regulation of hematopoietic stem cells by their mature progenyThrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.Increased differentiation of dermal mast cells in mice lacking the Mpl gene.Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severityRecombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.Eltrombopag and improved hematopoiesis in refractory aplastic anemia.Intron V, not intron I of human thrombopoietin, improves expression in the milk of transgenic mice regulated by goat beta-casein promoterProtected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.Romiplostim dose-response in patients with myelodysplastic syndromesPlatelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation.Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.The haematopoietic stem cell niche: new insights into the mechanisms regulating haematopoietic stem cell behaviourPharmacokinetic model of target-mediated disposition of thrombopoietin.Thrombopoietin levels in Quebec platelet disorder-Implications for the mechanism of thrombocytopenia.Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation.Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center
P2860
Q21296645-BBAE6856-58C4-4BBA-9617-87D6C24D60EAQ26863182-7CD7B94D-4376-48C7-A02F-E9F63EE8FA58Q28068881-967C38D4-FF49-4A69-9F53-353F3461120FQ28085299-4C42C2E0-E155-4164-8863-D61DD91430B1Q31010919-66C70556-D0CA-42E0-B9B1-53B1B3E9DAAFQ33371650-BC53196F-EF1A-4F91-9452-475438808D4AQ33382906-1D8849DB-FF8E-4933-9A1D-AA288E04C9A7Q33383468-1885B8A2-19AA-4C1F-A611-38ACEC4829F4Q33385976-3E5792AD-8155-4015-9631-1ED69C7E7264Q33387153-21F93C02-FBF0-49E0-8A2B-F6C1019EB8B2Q33387735-D4D6EFE0-BBC0-4050-9896-4B3C9095D42BQ33391229-CFD74366-BC11-4AF3-8909-35FFB5636877Q33400949-89EE118E-30D8-45F9-8014-583F6CACDAA0Q33405829-3D8CF87D-897B-4E6E-86B2-999C3F0E881CQ33408944-9B35EA74-1ED3-4122-8AF3-AF47E657F638Q33414491-F1CFEE49-B718-43F5-B4DD-8DD4F0E3A87AQ33429738-28674CA3-0495-4EA6-84B9-EC69AB3BB141Q33439412-96554964-ED55-4B2B-A2AF-921DD21AF270Q34392449-F0376B78-1632-4F58-B9BE-8DB1011E285DQ34411237-B04FE4EB-570F-4056-8F59-86E4A67B3029Q34549999-54D34DBE-D713-495E-9940-18BD4F876A77Q34555435-53F2057B-DDD1-4226-AA67-C3C8D844A67FQ35101887-0321E741-1D2F-4898-A765-25606873D32DQ35119918-9E9726F8-385B-4BE0-B793-18C1C33C10ABQ35226647-94D4610C-BBB8-46BA-9317-F4524D9A861FQ36174878-A7AB532D-15FF-4420-8919-B37DFAE2B2C1Q36242078-7DCF9BD2-3DEF-4669-B7AB-484F4C7ED55FQ36282619-4278C7A0-3BE8-4716-9389-6DFD003D32D5Q36948110-3B2F9421-4787-4A71-B2AF-B2CDE6C52827Q37499510-BD412286-5B20-4BDD-865E-CCD68100B361Q37725327-20059826-4515-49F7-98E6-40E1DABA889AQ37963879-7263C3F7-1C0B-4783-9417-932C6DD134D7Q42564517-9B7202A3-F97D-4C35-B80C-65FC62FF61F1Q48125691-821B458F-3C38-48FF-983D-F3563960576BQ49893762-6C587C7D-35A2-4297-822B-55EA6D0F82EFQ52581888-F2439F0D-109D-405F-AA7B-4BC63D2091E9Q52717647-12C16335-8843-4FDD-9A94-F59C48CAD8DEQ57494286-DB14D6F7-DACC-473A-8920-76395645A37A
P2860
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Human thrombopoietin levels ar ...... ncreased platelet destruction.
@ast
Human thrombopoietin levels ar ...... ncreased platelet destruction.
@en
type
label
Human thrombopoietin levels ar ...... ncreased platelet destruction.
@ast
Human thrombopoietin levels ar ...... ncreased platelet destruction.
@en
prefLabel
Human thrombopoietin levels ar ...... ncreased platelet destruction.
@ast
Human thrombopoietin levels ar ...... ncreased platelet destruction.
@en
P2093
P1433
P1476
Human thrombopoietin levels ar ...... increased platelet destruction
@en
P2093
P304
P407
P577
1996-05-01T00:00:00Z